CJC-1295 / Ipamorelin

Growth Hormone Optimization Subcutaneous Injectable

The gold-standard combination for natural growth-hormone optimization. CJC-1295 extends and amplifies the GH signal; Ipamorelin triggers clean GH release without affecting cortisol or prolactin. Used together, they nudge your pituitary to release your own GH in its natural pulsatile rhythm — safer and more physiologic than exogenous HGH.

Best for: Improved recovery, deeper sleep, body composition, skin quality, energy. Evening dosing.

Book Consult→ Get discounts with memberships →

Frequently Asked

What clients want to know about CJC-1295 / Ipamorelin

The questions, answered.

Stimulates natural growth hormone pulses — no exogenous HGH exposure.
Improves sleep depth and recovery.
Body composition gains: lean mass up, fat mass down, gradually.
Skin quality and elasticity improvements.
Better workout recovery and injury healing.
No cortisol or prolactin elevation (the clean profile of Ipamorelin).

CJC-1295: a GHRH analog that extends the GH-releasing signal.
Ipamorelin: a selective ghrelin-receptor agonist that triggers clean GH pulse.
Synergistic pulse amplification — combined effect exceeds either alone.
Preserves natural circadian GH rhythm unlike exogenous HGH.

Weeks 1–2: Deeper sleep and slightly faster recovery; mild fluid shifts settle.
Weeks 4–6: Body composition begins to shift; energy and skin tone improve.
Weeks 8–12: Significant changes in recovery, sleep architecture, and body composition consolidate.

Transient water retention — usually resolves in 2–3 weeks.
Mild fatigue or 'fullness' as the body adjusts.
Injection-site reactions — minor redness or itching.
Tingling or numbness in hands/feet — uncommon, dose-related.
Vivid dreams from deeper sleep architecture.

Dose at night on an empty stomach for maximum GH pulse.
No food 1 hour before/after — carbs and fat blunt the GH release.
Start at a conservative dose and titrate over 4 weeks.
Rotate injection sites across abdomen quadrants.

Active malignancy without oncology oversight.
Severe diabetic retinopathy.
Pregnancy or breastfeeding.
Critical illness or recent major surgery.

Important Note The FDA's position on peptides continues to evolve. Availability of specific compounds may change, and not all peptides discussed are currently offered at every visit. Book a consultation with our provider team to discuss your goals, current options, and what's appropriate for you.

CJC-1295 / Ipamorelin

The questions, answered.

Layered with intention.

Precision protocols.
Designed around you.

CJC-1295 / Ipamorelin

The questions, answered.

Layered with intention.

Precision protocols.Designed around you.

Precision protocols.
Designed around you.